Understanding how mosquitoes fight off viruses
Aedes antiviral RNAi pathway
This study is looking at how certain mosquitoes fight off viruses that cause diseases like dengue and chikungunya, with the goal of creating special mosquitoes that can help stop these illnesses from spreading.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10512058 on NIH RePORTER |
What this research studies
This research investigates the antiviral defense mechanisms in Aedes aegypti mosquitoes, focusing on the RNA interference (RNAi) pathway that helps them resist various arboviruses. By studying specific proteins involved in this pathway, the research aims to develop genetically modified mosquitoes that can effectively block the transmission of diseases like dengue and chikungunya. The approach includes creating mutant and transgenic mosquitoes to explore how these genetic changes affect their ability to combat viral infections. This work could lead to innovative strategies for controlling mosquito-borne diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas where arboviral infections like dengue and chikungunya are prevalent.
Not a fit: Patients who do not live in regions affected by arboviral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new methods for preventing the spread of dangerous mosquito-borne viruses, ultimately protecting public health.
How similar studies have performed: Other research has shown promise in using genetic modifications in mosquitoes to control disease transmission, indicating that this approach has potential for success.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Dimopoulos, George — Johns Hopkins University
- Study coordinator: Dimopoulos, George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.